STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
|
6 Months Ended |
Jun. 27, 2026 |
|---|
| Equity [Abstract] |
|
| SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY |
Restricted
stock activity for the six-month period ended June 27, 2026 was as follows:
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY
| | |
Shares | | |
Weighted
Average
Grant-Date
Fair Value | | |
Grant-Date
Fair Value | |
| Non-vested at December 27, 2025 | |
| 5,339,847 | | |
$ | 1.41 | | |
$ | 7,551,683 | |
| Granted | |
| 1,578,773 | | |
| 2.97 | | |
$ | 4,682,140 | |
| Forfeited | |
| (384,050 | ) | |
| 1.50 | | |
$ | (575,086 | ) |
| Vested | |
| (1,280,525 | ) | |
| 1.38 | | |
$ | (1,767,571 | ) |
| Non-vested at June 27, 2026 | |
| 5,254,045 | | |
$ | 1.88 | | |
| 9,891,166 | |
| Expected to vest | |
| 5,254,045 | | |
$ | 1.88 | | |
$ | 9,891,166 | |
|
| SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE |
The
following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted
common stock and stock options awards for the three and six months ended June 27, 2026 and June 28, 2025 (no tax benefits were recognized):
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE
| | |
Three Months
Ended | | |
Three Months
Ended | | |
Six Months
Ended | | |
Six Months
Ended | |
| | |
June 27, 2026 | | |
June 28, 2025 | | |
June 27, 2026 | | |
June 28, 2025 | |
| Cost of product revenues | |
$ | 70,169 | | |
$ | 86,569 | | |
$ | 120,177 | | |
$ | 226,006 | |
| Research and development | |
| 191,611 | | |
| 124,345 | | |
| 328,957 | | |
| 242,065 | |
| Selling, general and administrative | |
| 711,741 | | |
| 536,803 | | |
| 1,019,715 | | |
| 1,054,038 | |
| Total | |
$ | 973,521 | | |
$ | 747,717 | | |
$ | 1,468,849 | | |
$ | 1,522,109 | |
|
| SCHEDULE OF STOCK OPTIONS WEIGHTED AVERAGE OF ASSUMPTIONS |
The
fair value of this options award was estimated using the Black-Scholes model using the following assumptions and had the following fair
values:
SCHEDULE OF STOCK OPTIONS WEIGHTED AVERAGE OF ASSUMPTIONS
| | |
Three Months
Ended | | |
Six Months
Ended | |
| | |
June 27, 2026 | | |
June 27, 2026 | |
| Average risk-free interest rate | |
| 4.00 | % | |
| 4.00 | % |
| Expected dividend yield | |
| None | | |
| None | |
| Expected life (average, in years) | |
| 8.00 | | |
| 8.00 | |
| Expected volatility | |
| 90.00 | % | |
| 90.00 | % |
| Weighted average exercise price | |
$ | 3.21 | | |
$ | 3.21 | |
| Weighted average fair value | |
$ | 2.07 | | |
$ | 2.07 | |
|
| SUMMARY OF STOCK OPTION ACTIVITY |
A
summary of stock option activity for the period ended June 27, 2026 is as follows:
SUMMARY OF STOCK OPTION ACTIVITY
| | |
Number of
Options | | |
Weighted
Average
Exercise Price | | |
Intrinsic
Value | |
| Outstanding as of December 27, 2025 | |
| 591,366 | | |
$ | 1.76 | | |
$ | 366,647 | |
| Granted | |
| 724,638 | | |
$ | 3.21 | | |
| — | |
| Outstanding as of June 27, 2026 | |
| 1,316,004 | | |
$ | 2.56 | | |
$ | — | |
| Options exercisable as of June 27, 2026 | |
| 312,342 | | |
$ | 2.18 | | |
$ | — | |
|